CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −7,689 | 23,068 | ||
| 2024-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +3,114 | 9,573 | ||
| 2024-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −908 | $28.91 | $26K | 8,665 |
| 2024-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −3,114 | 3,114 | ||
| 2024-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +7,108 | 75,922 | ||
| 2024-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −3,156 | $28.91 | $91K | 72,766 |
| 2024-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −7,108 | 7,109 | ||
| 2024-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,654 | 281,393 | ||
| 2024-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −1,929 | $28.91 | $56K | 279,464 |
| 2024-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,654 | 5,655 | ||
| 2024-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +9,693 | 157,249 | ||
| 2024-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −4,304 | $28.91 | $124K | 152,945 |
| 2024-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −9,693 | 9,694 | ||
| 2024-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +12,278 | 110,886 | ||
| 2024-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −5,452 | $28.91 | $158K | 105,434 |
| 2024-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −12,278 | 12,279 | ||
| 2024-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,431 | 163,807 | ||
| 2024-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,300 | $28.91 | $95K | 160,507 |
| 2024-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,431 | 7,432 | ||
| 2024-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +7,108 | 116,262 |
Page 26 of 41 · 804 trades